Literature DB >> 15717607

Effect of tetraalkylammonium derivatives of 6-methyluracil on the endplate potentials of muscles of different functional types.

I V Kovyazina1, K A Petrov, V V Zobov, E A Bukharaeva, E E Nikolsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15717607     DOI: 10.1007/s10630-005-0011-3

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN: 0012-4966


× No keyword cloud information.
  4 in total

1.  Isolation and characterization of the surface membranes of fast and slow mammalian skeletal muscle.

Authors:  P B Smith; S H Appel
Journal:  Biochim Biophys Acta       Date:  1977-04-01

2.  [Features of the postsynaptic potentials and ion currents in synapses of fast and slow rat muscle fibers].

Authors:  V V Fedorov
Journal:  Neirofiziologiia       Date:  1980

3.  Electrophysiologic differences between mouse extensor digitorum longus and soleus.

Authors:  J A Florendo; J F Reger; P K Law
Journal:  Exp Neurol       Date:  1983-11       Impact factor: 5.330

4.  Postjunctional characteristics of the endplates in mammalian fast and slow muscles.

Authors:  R Sterz; M Pagala; K Peper
Journal:  Pflugers Arch       Date:  1983-06       Impact factor: 3.657

  4 in total
  2 in total

1.  Effect of a tetraalkylammonium derivative of 6-methyluracil from a new class of acetylcholinesterase inhibitors on the endplate potential amplitude in muscles of different function types under high-frequency nerve stimulation.

Authors:  K A Petrov; I V Kovyazina; V V Zobov; E A Bukharaeva; V S Reznik; E E Nikolsky
Journal:  Dokl Biol Sci       Date:  2007 Jul-Aug

2.  Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS).

Authors:  Konstantin A Petrov; Lilia O Yagodina; Guzel R Valeeva; Natalya I Lannik; Alexandra D Nikitashina; Albert A Rizvanov; Vladimir V Zobov; Ellya A Bukharaeva; Vladimir S Reznik; Eugeny E Nikolsky; František Vyskočil
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.